Editor's note: This article is forw...

Editor's note: This article is forward updated reprint of the renal transplantation place of abode Study published in the AORN Journal in December 1998

In 1902 French-American surgeon Alexis Carrel, MD actionsed the first experimental renal transplantations in animals at the Rockefeller Institute for Medical Research in of the present day York. He developed the techniques of surgical anastomosis that still are used according to surgeons today. The first auspicious human renal transplantation was performed in 1945 Three surgeon surgically cohereed a cadaveric (ie, deceased donor) renal graft to the upper extremity canals of a patient who was in acute renal failure from septicemia. The graft remained in place for solely two days until the patient's concede renal function recovered. (1)

With the advent of dialysis in 1950 surgeon attempted renal transplantation upon other patients. In 1951, surgeon began cadaveric allotransplantation. Initial attempts were not fortunate because they did not use pharmacological immunosuppression. The first living-related donor renal transplantation was performed in 1953 from a surgeon in Paris. The graft was bring to noughted by rejection in 22 days. The first prosperous living-related donor renal transplantation was performed in 1954 Ronald Herrick donated a kidney to his identical twin brother, Richard, at Peter brant Brigham Hospital in Boston. Richard lived seven years after the transplantation. (2)

Living-related and cadaveric renal transplantations became a more feasible option with the clinical introduction of azathioprine, an immunosuppressant medication used to interrupt rejection. The use of azathioprine and prednisone, a corticosteroid that suppresse cell-mediated immunity, was demonstrated to bear an acceptable renal graft survival rate. Furthermore, fresh organ preservation methods allowed for retrieval and shipment of cadaveric organs, and the introduction of cyclosporine, a powerful immunosuppressant, increased survival rates among patients undergoing transplantations. (3)

STATISTICS

More than 10000 renal transplantations are performed each year on patients with end-stage renal disease (ESRD) In 2000 13372 renal transplantations were performed. Of these, 5293 kidneys came from living donors. Studies have demonstrated that patients who receive donor kidneys live longer than those onward dialysis; however, approximately eight to nine patients die each day while waiting for a transplantation because of the shortage of donors. More than united half of all kidney recipients receive an organ from a cadaveric donor. The average waiting period for a suitable cadaveric kidney may be more than sum of two units years, and only 15% to 20% of patients waiting for transplants receive them. (4)

In the United States, an estimated 25000 potential donors die each year, and merely about 5,500 have made arrangements to donate their organs. The number of cadaveric donor organs restoreed in 2000 totaled 5,984. It is estimated that each available kidney optimally matches simply one person out of a loch of 1,000 recipients. (5) Although transplantation increasingly is being made available to older patients with ESRD it still is predominately a therapy for younger patients. Two-thirds of population with ESRD are 55 years of age or older on the other hand these patients account for solitary 17% of all transplantations. Unfortunately, many older race with ESRD do not suited the criteria for transplantation. generally in the United States, more than 80000 the bulk of mankind are living with functioning renal transplants. (6)

The United Network for Organ Sharing (UNOS) is a private, nonprofit organization that operates the national Organ agency and Transplantation Network and the national Scientific Registry of Transplantation Recipients. each 20 minutes, a new name is added to the UNOS national waiting list, and the list shoots by approximately 17% each year. More than 50000 patients are waiting for a life-saving renal transplantation. (7)

Transplantation succes rates vary depending forward the cause of renal failure. The highest succes rates are lay the foundation of in patients with

* cystic kidney disease (52%)

* glomerulonephritis (45%) and

* obstructive nephropathy (30%)

The lowest succes rates are ground in patients with diabetes (17%) and hypertension (16%)

through every part of the years, the primary diagnosis as an indication for transplantation has changed. Among living donor recipients, the number of patients diagnosed with glomerulonephritis has decreased, and the number of patients with a diagnosis of polycystic kidneys has increased. Among cadaveric renal recipients, patients with a diagnosis of glomerulonephritis have decreased, and patients with a diagnosis of diabetes have increased. (8)

DONORS

For a patient with ESRD renal transplantation is the barely treatment that restores reasonably normal health. Renal transplantation is the surgical insertion of a human kidney from a living or cadaveric source into a patient with ESRD A donor is exigencyed when a patient's

* serum creatinine is approximately 5 mg by dL,